Healwell Al Inc
TSX:AIDX
Healwell Al Inc
Healwell Al Inc is a CA-based company operating in Health Care Providers & Services industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2007-04-25. HEALWELL AI Inc., formerly MCI Onehealth Technologies Inc., is a healthcare technology company focused on artificial intelligence (AI) and data science for preventative care. The firm is engaged in developing and acquiring technology and clinical sciences capabilities. Its clinical information sources consist of clinician and electronic medical records (EMR) access; clinical research and rials; lab and diagnostic info, and semi-structured data. The company offers a range of clinical insights with life sciences companies, precision medicine companies, pharmaceutical companies, and medical device companies.
Healwell Al Inc is a CA-based company operating in Health Care Providers & Services industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2007-04-25. HEALWELL AI Inc., formerly MCI Onehealth Technologies Inc., is a healthcare technology company focused on artificial intelligence (AI) and data science for preventative care. The firm is engaged in developing and acquiring technology and clinical sciences capabilities. Its clinical information sources consist of clinician and electronic medical records (EMR) access; clinical research and rials; lab and diagnostic info, and semi-structured data. The company offers a range of clinical insights with life sciences companies, precision medicine companies, pharmaceutical companies, and medical device companies.
Revenue Surge: HEALWELL reported Q3 2025 revenue of $30.4 million, up 354% year-over-year, mainly due to the Orion Health acquisition and strong organic and inorganic growth.
Profitability Milestone: The company achieved positive adjusted EBITDA of $0.7 million, marking its second consecutive quarter of profitability.
Business Simplification: HEALWELL completed a major business simplification, transforming into a pure-play AI and software company after divesting non-core assets.
AI Expansion: Integration of the DARWEN AI platform into Amadeus software and full ownership of Pentavere expanded HEALWELL's AI capabilities and commercialization efforts.
Strong Cash Position: Ended Q3 with $15.6 million in cash, up from $9.4 million at the end of Q4 2024, supporting growth initiatives.
Global Growth: Announced a joint venture with WELL Health and a partnership with Lean Business Services to expand into the Middle East, with ongoing commercial activity in North America and among top global pharmaceutical companies.
Focus on Commercial Validation: Management emphasized disciplined investment, operating margin improvement, and plans to demonstrate commercial AI validation in health care systems outside life sciences in 2026.
